Bharat Biotech starts phase III trials for COVAXIN

Nov 17, 2020

Hyderabad [India], November 17, : Bharat Biotech announced the commencement of Phase III trials of COVAXIN on Monday.

Bharat Biotech's Covaxin phase 3 data shows 77.8 pc efficacy against COVID-19, says Lancet

Nov 12, 2021

Hyderabad (Telangana) [India], November 12 : Hyderabad-based Bharat Biotech on Friday announced that the Lancet peer-review confirmed the efficacy analysis of Bharat Biotech's Covaxin.

Covaxin is 200% safe, says Bharat Biotech Chairman

Jan 04, 2021

Hyderabad (Telangana) [India], January 4 : Covaxin, the indigenous vaccine developed by Bharat Biotech against COVID-19 in collaboration with ICMR, is 200 per cent...

Japan approves COVAXIN booster dose for travellers: Bharat Biotech

Aug 05, 2022

Hyderabad [Telangana], August 5 : Hyderabad-based Bharat Biotech on Friday announced that Japan has approved the COVAXIN booster dose for travellers.

Bharat Biotech donates 2 lakh Covaxin doses to Vietnam

Dec 16, 2021

New Delhi [India], December 16 : Hyderabad-based biotechnology company Bharat Biotech on Thursday announced that it will donate two lakh doses of its COVID-19...

Bharat Biotech bosses discuss Covaxin status with Vice-President

Dec 25, 2020

Hyderabad (Telangana) [India], December 25 : Bharat Biotech Chairman and Managing Director Dr Krishna Ella and Joint Managing Director Suchitra Ella called on Vice-President...